Devices › Stimulator, spinal-cord, totally implanted for pain relief
Device brand name · Stimulator spinal-cord totally implanted for
Implantable Neurostimulator: medical device reports filed with FDA
6,395 reports name it, 2005–2026. Manufacturer given most often on reports: Medtronic Neuromodulation. Product code LGW.
- 6,395
- device reports naming the brand
- 0% of all MAUDE reports · about 306 a year
- 692
- reports, 12 months to August 2026
- 756 in the 12 months before
- 63.6%
- classified as malfunction
- 27.3% across the product code
- 0.3%
- classified as death, as reported
- 22 reports · not verified by FDA
6,395 medical device reports received by FDA name the brand "Implantable Neurostimulator" (stimulator spinal-cord totally implanted for); the manufacturer given most often on reports is Medtronic Neuromodulation; received from August 2005 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
692 reports arrived in the 12 months to August 2026, close to the 756 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (63.6%), injury (36%) and death (0.3%); across all stimulator, spinal-cord, totally implanted for pain relief reports (product code LGW) death is recorded in 0.5% and malfunction in 27.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are connection problem (18.7%), material integrity problem (16%) and insufficient device problem information (15.5%). The patient problems coded most often are pain, therapeutic effects, unexpected and electric shock. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 378,355 reports carrying product code LGW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Connection problema connection problem | 1,198 | 18.7% | 1.6% |
| Material integrity problema problem with the device material | 1,025 | 16% | 0.9% |
| Insufficient device problem information | 990 | 15.5% | 6.8% |
| Charging problem | 666 | 10.4% | 11.2% |
| High impedance | 536 | 8.4% | 9.7% |
| Overheating of device | 503 | 7.9% | 3.5% |
| Failure to power up | 485 | 7.6% | 0.8% |
| Breakthe device broke | 358 | 5.6% | 1.4% |
| Migration or expulsion of device | 313 | 4.9% | 4.7% |
| Communication or transmission problemthe device could not communicate or transmit | 293 | 4.6% | 5% |
| Battery problema problem with the battery | 290 | 4.5% | 7.8% |
| Failure to deliver energy | 259 | 4.1% | 4.4% |
| Display or visual feedback problem | 230 | 3.6% | 0.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 220 | 3.4% | 7.5% |
| Inappropriate/inadequate shock/stimulation | 220 | 3.4% | 3.7% |
| Failure to interrogate | 195 | 3% | 2.2% |
| Malposition of device | 147 | 2.3% | 1.3% |
| Impedance problem | 136 | 2.1% | 1.9% |
| Energy output problem | 134 | 2.1% | 1.9% |
| Electromagnetic compatibility problem | 108 | 1.7% | 0.8% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Painpain, site not specified | 463 | 7.2% |
| Therapeutic effects, unexpected | 235 | 3.7% |
| Electric shockan electric shock | 216 | 3.4% |
| Complaint, ill-defined | 135 | 2.1% |
| Therapeutic response, decreased | 133 | 2.1% |
| Burning sensationa burning feeling | 120 | 1.9% |
| Discomfortdiscomfort | 108 | 1.7% |
| Intracranial hemorrhage | 104 | 1.6% |
| Ambulation or postural difficulties | 80 | 1.3% |
| Cognitive changes | 80 | 1.3% |
| Inadequate pain relief | 80 | 1.3% |
| Erosion | 66 | 1% |
| Undesired nerve stimulation | 57 | 0.9% |
| Convulsion/seizure | 53 | 0.8% |
| Hematomaa collection of blood under the skin or in tissue | 52 | 0.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Implantable Neurostimulator | Product code LGW | All MAUDE reports |
|---|---|---|---|
| Reports | 6,395 | 378,355 | 26,136,888 |
| Share of that pool | — | 1.7% | 0% |
| Classified as death, per 1,000 reports | 3 | 5 | 9 |
| Classified as injury | 36% | 72% | 36.2% |
| Classified as malfunction | 63.6% | 27.3% | 62.3% |
| Filed by the manufacturer | 99.6% | 99.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LGW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Intellis | 42,032 | 4,743 | 0% |
| Octrode Lead Kit, 60cm Length | 47,037 | 5,133 | 0.1% |
| SureScan | 33,123 | 490 | 0% |
| Precision? | 26,020 | 446 | 0.4% |
| Proclaim 5 Elite Implantable Pulse Generator | 20,816 | 2,057 | 0.1% |
| Precision Spectra ? | 16,858 | 971 | 0.5% |
| Restore Ultra | 13,500 | 39 | 0.1% |
| Eon Mini IPG, 16-Channel Rechargeable | 14,176 | 111 | 0.2% |
| Restore Sensor | 10,934 | 40 | 0.1% |
| Spectra WaveWriter? | 7,766 | 1,093 | 0.4% |
| Penta 3mm Lead, 60 cm | 9,617 | 839 | 0.3% |
| Senza | 6,423 | 718 | 15.1% |
| Eon Mini | 9,122 | 0 | 0.6% |
| Proclaim 7 Elite Implantable Pulse Generator | 5,836 | 333 | 0.1% |
| WaveWriter Alpha? | 4,965 | 1,591 | 0.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Implantable Neurostimulator reports
How many FDA reports name Implantable Neurostimulator?
6,395 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 692 in the latest 12 months.
What kinds of events are reported?
malfunction (63.6%), injury (36%) and death (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
connection problem (18.7%), material integrity problem (16%), insufficient device problem information (15.5%), charging problem (10.4%) and high impedance (8.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.6%) and voluntary reports (0.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Implantable Neurostimulator was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.